Company
Solventum Corp (SOLV)
Standardized SEC financial data for Solventum Corp — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001964738 · NYSE · Surgical & Medical Instruments & Apparatus.
Gross margin
53.5%
Operating margin
26.2%
Net margin
18.7%
Revenue growth (YoY)
0.9%
Return on equity
30.8%
ROIC
21.5%
Free cash flow
-$10.0M
Debt / equity
1.00×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $8.13B | $8.20B | $8.25B | $8.32B |
| Gross profit | $4.70B | $4.69B | $4.59B | $4.45B |
Cash flow
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | $1.68B | $1.92B | $1.19B | $369.0M |
| Capital expenditures | $251.0M | $290.0M | $380.0M | $379.0M |
Get SOLV data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/SOLV/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/SOLV/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"